Numerous studies have revealed that nanoselenium modulates immune cell activity by increasing selenoprotein levels, making it a potential therapeutic agent for conditions such as viral pneumonia [62,63], colitis [64], heart disease [65,66], ischemia/reperfusion damage [67], cancer [68,69,70], and other diseases. The gene discussed is SELENOS; the disease is colitis.